Panaxia Labs Israel Ltd PNAX.TA Stock
Panaxia Labs Israel Ltd Price Chart
Panaxia Labs Israel Ltd PNAX.TA Financial and Trading Overview
| Panaxia Labs Israel Ltd stock price | 12670 ILA |
| Previous Close | 49.9 ILA |
| Open | 49.9 ILA |
| Bid | 43.3 ILA x N/A |
| Ask | 49.9 ILA x N/A |
| Day's Range | 47.9 - 47.9 ILA |
| 52 Week Range | 45 - 650 ILA |
| Volume | 1K ILA |
| Avg. Volume | 23.16K ILA |
| Market Cap | 7.17M ILA |
| Beta (5Y Monthly) | -0.370814 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 ILA |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | June 3, 2012 |
| 1y Target Est | N/A |
PNAX.TA Valuation Measures
| Enterprise Value | 43.59M ILA |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.18192618 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.106 |
| Enterprise Value/EBITDA | -1.2 |
Trading Information
Panaxia Labs Israel Ltd Stock Price History
| Beta (5Y Monthly) | -0.370814 |
| 52-Week Change | -90.23% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 650 ILA |
| 52 Week Low | 45 ILA |
| 50-Day Moving Average | 76.76 ILA |
| 200-Day Moving Average | 218.62 ILA |
PNAX.TA Share Statistics
| Avg. Volume (3 month) | 23.16K ILA |
| Avg. Daily Volume (10-Days) | 1.13K ILA |
| Shares Outstanding | 14.97M |
| Float | 12.91M |
| Short Ratio | N/A |
| % Held by Insiders | 78.68% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -109.76% |
| Operating Margin (ttm) | -95.82% |
| Gross Margin | -52.85% |
| EBITDA Margin | -92.17% |
Management Effectiveness
| Return on Assets (ttm) | -36.76% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 39.42M ILA |
| Revenue Per Share (ttm) | 2.63 ILA |
| Quarterly Revenue Growth (yoy) | -76.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | -36334000 ILA |
| Net Income Avi to Common (ttm) | -43270000 ILA |
| Diluted EPS (ttm) | -2.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.8M ILA |
| Total Cash Per Share (mrq) | 0.19 ILA |
| Total Debt (mrq) | 38.91M ILA |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.641 |
| Book Value Per Share (mrq) | -1.479 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9008000 ILA |
| Levered Free Cash Flow (ttm) | -1403375 ILA |
Profile of Panaxia Labs Israel Ltd
| Country | Israel |
| State | N/A |
| City | Lod |
| Address | Bat Sheva 1 |
| ZIP | 7120101 |
| Phone | 972 7 2274 4144 |
| Website | https://panaxia.co.il |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 59 |
Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was incorporated in 2005 and is based in Lod, Israel.
Q&A For Panaxia Labs Israel Ltd Stock
What is a current PNAX.TA stock price?
Panaxia Labs Israel Ltd PNAX.TA stock price today per share is 12670 ILA.
How to purchase Panaxia Labs Israel Ltd stock?
You can buy PNAX.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Panaxia Labs Israel Ltd?
The stock symbol or ticker of Panaxia Labs Israel Ltd is PNAX.TA.
Which industry does the Panaxia Labs Israel Ltd company belong to?
The Panaxia Labs Israel Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Panaxia Labs Israel Ltd have in circulation?
The max supply of Panaxia Labs Israel Ltd shares is 1.5K.
What is Panaxia Labs Israel Ltd Price to Earnings Ratio (PE Ratio)?
Panaxia Labs Israel Ltd PE Ratio is 0.00000000 now.
What was Panaxia Labs Israel Ltd earnings per share over the trailing 12 months (TTM)?
Panaxia Labs Israel Ltd EPS is 0 ILA over the trailing 12 months.
Which sector does the Panaxia Labs Israel Ltd company belong to?
The Panaxia Labs Israel Ltd sector is Healthcare.